Further promote technological innovation in aging and elderly care services

Recently, the "Guiding Opinions on Further Promoting Technological Innovation in Civil Affairs" (hereinafter referred to as the "Opinions") were issued. The issuance and implementation of the document ...

Give full play to the stabilizing role of universal insurance

For a period of time, universal home property insurance has rapidly developed nationwide, and by the end of 2025, the cumulative number of implemented projects has exceeded 40. In Beijing, the "Puhui ...

Electronic outerwear enables precise drug delivery

According to Beihang University, Professor Chang Lingqian's team from the School of Medical Science and Engineering and Professor Xu Ye's team from the School of Mechanical Engineering and Automation ...

The State Administration for Market Regulation solicited public opinions from the society

It has been learned from the State Administration for Market Regulation that the State Administration for Market Regulation has organized the revision of the "Detailed Rules for the Examination of Veg ...

Optimizing the environment to stimulate the potential of healthy consumption

The National Business Work Conference held during the period proposed to develop digital consumption, green consumption, and healthy consumption, and stimulate the consumption vitality of the sinking ...

Collaborative development of elderly care and industry

In 2025, the central government will allocate approximately 1.2 trillion yuan in basic pension insurance subsidies, and the Ministry of Civil Affairs and eight other departments will jointly issue the ...

Build a 'Health Station'! 9 departments issue documents to promote high-quality development of the pharmaceutical retail industry

The opinions on promoting high-quality development of the pharmaceutical retail industry jointly issued by the Ministry of Commerce and 9 other departments were released on January 22, proposing a tot ...

Recently, the first leukemia CAR-T therapy drug in China with fully independent intellectual property rights, Nakiolenza Injection, entered the first batch of commercial insurance innovative drug cata ...